- call +1-201-465-4211
- email sales@mrinsights.biz
Hematopoietic stem cell transplants (HSCT) present to a valid treatment for several congenital and other hematopoietic system disorders, post chemotherapy, and immune sensitive diseases. HSCT is also preferred for replacement of cellular components and deficient cells. The indications for HSCT thus are wide; the most frequent indication as per reported by Worldwide Network for Blood and Marrow Transplantation Group (WNBT) (2013) is lymphoproliferative disorder (53.2% of all HSCT), 12% of whom received allogeneic and the rest received autologous transplant. Plasma cell disorders are the most frequent indication in this group. A multitude of literature published by researchers and organizations demonstrate that autologous transplant own a greater edge against allogeneic HSCT.
Scope of the Report:
This report studies the Hematopoietic Stem Cells Transplantation market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hematopoietic Stem Cells Transplantation market by product type and applications/end industries.
Over 30 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone. Further application of this approach it may eventually be able to treat a wide array of conditions and replace ailing tissues. However, despite the vast experience with HSCs, researchers face major barriers in expanding their use beyond the replacement of immune and blood cells.
Hematopoietic stem cells are unable to proliferate and differentiate in-vitro. Researchers have yet to evolve an accurate method to differentiate stem cells from other cells derived from blood or bone marrow. Once such technical barriers are overcome, the avenues for realizing the full potential of HSCT. The type of transplant a person receives depends on several different factors, including the type and course of the disease, availability of suitable donors, and the patient’s overall health. There are three different sources of hematopoietic stem cells such as bone marrow, peripheral blood stem cells, and umbilical cord blood. The stem cell source used for a given transplant depends upon the underlying disease, the type of transplant (allogeneic or autologous), and size of the patient.
The global Hematopoietic Stem Cells Transplantation market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hematopoietic Stem Cells Transplantation.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Kite Pharma
Thermo Fisher Scientific
CellGenix Technologie Transfer
Cesca Therapeutics
R&D Systems
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Autologous Transplant
Allogenic Transplant
Market Segment by Applications, can be divided into
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hematopoietic Stem Cells Transplantation Market Overview
1.1 Product Overview and Scope of Hematopoietic Stem Cells Transplantation
1.2 Classification of Hematopoietic Stem Cells Transplantation by Types
1.2.1 Global Hematopoietic Stem Cells Transplantation Revenue Comparison by Types (2017-2023)
1.2.2 Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Types in 2017
1.2.3 Autologous Transplant
1.2.4 Allogenic Transplant
1.3 Global Hematopoietic Stem Cells Transplantation Market by Application
1.3.1 Global Hematopoietic Stem Cells Transplantation Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Leukemia
1.3.3 Lymphoproliferative Disorders
1.3.4 Solid Tumors
1.3.5 Non-Malignant Disorders
1.3.6 Others
1.4 Global Hematopoietic Stem Cells Transplantation Market by Regions
1.4.1 Global Hematopoietic Stem Cells Transplantation Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hematopoietic Stem Cells Transplantation Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hematopoietic Stem Cells Transplantation Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hematopoietic Stem Cells Transplantation Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hematopoietic Stem Cells Transplantation Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hematopoietic Stem Cells Transplantation Status and Prospect (2013-2023)
1.5 Global Market Size of Hematopoietic Stem Cells Transplantation (2013-2023)
2 Manufacturers Profiles
2.1 Kite Pharma
2.1.1 Business Overview
2.1.2 Hematopoietic Stem Cells Transplantation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Kite Pharma Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher Scientific
2.2.1 Business Overview
2.2.2 Hematopoietic Stem Cells Transplantation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Thermo Fisher Scientific Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.3 CellGenix Technologie Transfer
2.3.1 Business Overview
2.3.2 Hematopoietic Stem Cells Transplantation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CellGenix Technologie Transfer Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cesca Therapeutics
2.4.1 Business Overview
2.4.2 Hematopoietic Stem Cells Transplantation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cesca Therapeutics Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2016-2017)
2.5 R&D Systems
2.5.1 Business Overview
2.5.2 Hematopoietic Stem Cells Transplantation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 R&D Systems Hematopoietic Stem Cells Transplantation Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hematopoietic Stem Cells Transplantation Market Competition, by Players
3.1 Global Hematopoietic Stem Cells Transplantation Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hematopoietic Stem Cells Transplantation Players Market Share
3.2.2 Top 10 Hematopoietic Stem Cells Transplantation Players Market Share
3.3 Market Competition Trend
4 Global Hematopoietic Stem Cells Transplantation Market Size by Regions
4.1 Global Hematopoietic Stem Cells Transplantation Revenue and Market Share by Regions
4.2 North America Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
4.3 Europe Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
4.5 South America Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
5 North America Hematopoietic Stem Cells Transplantation Revenue by Countries
5.1 North America Hematopoietic Stem Cells Transplantation Revenue by Countries (2013-2018)
5.2 USA Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
5.3 Canada Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
5.4 Mexico Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
6 Europe Hematopoietic Stem Cells Transplantation Revenue by Countries
6.1 Europe Hematopoietic Stem Cells Transplantation Revenue by Countries (2013-2018)
6.2 Germany Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
6.3 UK Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
6.4 France Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
6.5 Russia Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
6.6 Italy Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hematopoietic Stem Cells Transplantation Revenue by Countries
7.1 Asia-Pacific Hematopoietic Stem Cells Transplantation Revenue by Countries (2013-2018)
7.2 China Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
7.3 Japan Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
7.4 Korea Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
7.5 India Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
8 South America Hematopoietic Stem Cells Transplantation Revenue by Countries
8.1 South America Hematopoietic Stem Cells Transplantation Revenue by Countries (2013-2018)
8.2 Brazil Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
8.3 Argentina Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
8.4 Colombia Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hematopoietic Stem Cells Transplantation by Countries
9.1 Middle East and Africa Hematopoietic Stem Cells Transplantation Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
9.3 UAE Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
9.4 Egypt Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
9.6 South Africa Hematopoietic Stem Cells Transplantation Revenue and Growth Rate (2013-2018)
10 Global Hematopoietic Stem Cells Transplantation Market Segment by Type
10.1 Global Hematopoietic Stem Cells Transplantation Revenue and Market Share by Type (2013-2018)
10.2 Global Hematopoietic Stem Cells Transplantation Market Forecast by Type (2018-2023)
10.3 Autologous Transplant Revenue Growth Rate (2013-2023)
10.4 Allogenic Transplant Revenue Growth Rate (2013-2023)
11 Global Hematopoietic Stem Cells Transplantation Market Segment by Application
11.1 Global Hematopoietic Stem Cells Transplantation Revenue Market Share by Application (2013-2018)
11.2 Hematopoietic Stem Cells Transplantation Market Forecast by Application (2018-2023)
11.3 Leukemia Revenue Growth (2013-2018)
11.4 Lymphoproliferative Disorders Revenue Growth (2013-2018)
11.5 Solid Tumors Revenue Growth (2013-2018)
11.6 Non-Malignant Disorders Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)
12 Global Hematopoietic Stem Cells Transplantation Market Size Forecast (2018-2023)
12.1 Global Hematopoietic Stem Cells Transplantation Market Size Forecast (2018-2023)
12.2 Global Hematopoietic Stem Cells Transplantation Market Forecast by Regions (2018-2023)
12.3 North America Hematopoietic Stem Cells Transplantation Revenue Market Forecast (2018-2023)
12.4 Europe Hematopoietic Stem Cells Transplantation Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hematopoietic Stem Cells Transplantation Revenue Market Forecast (2018-2023)
12.6 South America Hematopoietic Stem Cells Transplantation Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hematopoietic Stem Cells Transplantation Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hematopoietic Stem Cells Transplantation Picture
Table Product Specifications of Hematopoietic Stem Cells Transplantation
Table Global Hematopoietic Stem Cells Trans
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
